Activation of the CXCL12/CXCR4 signaling axis may drive vascularization of the ovine placenta

被引:31
|
作者
Quinn, K. E. [1 ]
Ashley, A. K. [1 ]
Reynolds, L. P. [2 ]
Grazul-Bilska, A. T. [2 ]
Ashley, R. L. [1 ]
机构
[1] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA
[2] N Dakota State Univ, Ctr Nutr & Pregnancy, Dept Anim Sci, Fargo, ND 58108 USA
基金
美国食品与农业研究所;
关键词
CXCL12; CXCR4; VEGF; Vascularization; Pregnancy; Sheep; STROMAL-DERIVED FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; MATERNAL-FETAL INTERFACE; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; EARLY-PREGNANCY; TH2; BIAS; FACTOR-I; ANGIOGENESIS; EXPRESSION;
D O I
10.1016/j.domaniend.2013.12.004
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Early pregnancy, when most embryonic losses occur, is a critical period in which vital placental vascularization is established. Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis, and factors that regulate VEGF function, expression, or both may ultimately affect vascularization. Activation of the C-X-C chemokine receptor type 4 (CXCR4) by its cognate ligand, C-X-C chemokine ligand 12 (CXCL12), increases VEGF synthesis and secretion, which in turn stimulates CXCL12 and CXCR4 production and this synergistic regulation may influence placental vascularization. We hypothesized that expression of CXCL12, CXCR4, select angiogenic factors, and their receptors would increase in placental tissues during early pregnancy and that treatment of ovine trophectoderm cells with CXCL12 would increase production of angiogenic factors. To test this hypothesis, maternal caruncle (CAR) and fetal extraembryonic membrane (FM) tissues were collected on days 18, 20, 22, 25, 26, and 30 of pregnancy and on day 10 of the estrous cycle (control, NP) to determine relative mRNA or protein expression of CXCL12 and CXCR4 and selected angiogenic factors. In CAR, expression of mRNA for CXCR4 increased on day 18, 20, 22, and 25 and CXCL12 increased on day 18 and 20 compared with NP ewes. CXCL12 protein followed a similar pattern in CAR tissue, with greater levels on day 20 than in NP tissue. Greater levels of fibroblast growth factor 2 (FGF2) mRNA was observed in CAR on day 20 of gestation than on day 30. In FM, CXCL12, CXCR4, angiopoietin 1, VEGF, and VEGF receptor 1 were enhanced with advancing pregnancy, whereas FGF2 and kinase insert domain receptor (or VEGF receptor 2) peaked on day 25. An increase in protein levels occurred on day.25 compared with day 20 in FM for CXCL12 and CXCR4, as well as a similar tendency for FGF2 protein. Both CXCL12 and CXCR4 are specifically localized to trophoblast cells and to the uterine luminal and glandular epithelium. Treatment of ovine trophectoderm cells with CXCL12 increased mRNA expression for VEGF and FGF2. The relationship between VEGF, FGF2, and the CXCL12/CXCR4 signaling underscores the potential role for this chemokine axis in driving placentation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 50 条
  • [1] CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
    Wu, Xia
    Wang, Ying
    Li, Min
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [2] Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
    Hinton, Cimona V.
    Avraham, Shalom
    Avraham, Hava Karsenty
    CLINICAL & EXPERIMENTAL METASTASIS, 2010, 27 (02) : 97 - 105
  • [3] The CXCR4/CXCL12 axis in endometrial cancer
    Gelmini, Stefania
    Mangoni, Monica
    Castiglione, Francesca
    Beltrami, Cristina
    Pieralli, Annalisa
    Andersson, Karin Louise
    Fambrini, Massimiliano
    Taddei, Gian Luigi
    Serio, Mario
    Orlando, Claudio
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (03) : 261 - 268
  • [4] Role of CXCL12/CXCR4 signaling axis in pancreatic cancer
    Wu Peng-fei
    Lu Zi-peng
    Cai Bao-bao
    Tian Lei
    Zou Chen
    Jiang Kui-rong
    Miao Yi
    CHINESE MEDICAL JOURNAL, 2013, 126 (17) : 3371 - 3374
  • [5] The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma
    Mitchell, B.
    Mahalingam, M.
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (12) : 1539 - 1546
  • [6] CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
    Sun, Xueqing
    Cheng, Guangcun
    Hao, Mingang
    Zheng, Jianghua
    Zhou, Xiaoming
    Zhang, Jian
    Taichman, Russell S.
    Pienta, Kenneth J.
    Wang, Jianhua
    CANCER AND METASTASIS REVIEWS, 2010, 29 (04) : 709 - 722
  • [7] CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target
    Terasaki, Mizuhiko
    Sugita, Yasuo
    Arakawa, Fumiko
    Okada, Yosuke
    Ohshima, Koichi
    Shigemori, Minoru
    BRAIN TUMOR PATHOLOGY, 2011, 28 (02) : 89 - 97
  • [8] Placental insufficiency and heavier placentas in sheep after suppressing CXCL12/CXCR4 signaling during implantation
    Ashley, Ryan L.
    Trigo, Elisa M.
    Ervin, Jacqueline M.
    BIOLOGY OF REPRODUCTION, 2023, 109 (06) : 982 - 993
  • [9] The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor
    Kasina, Sathish
    Macoska, Jill A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 351 (02) : 249 - 263
  • [10] Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
    Cimona V. Hinton
    Shalom Avraham
    Hava Karsenty Avraham
    Clinical & Experimental Metastasis, 2010, 27 : 97 - 105